FdaApplication
ANDA 204065
Identifiers
- fda_app_no: ANDA204065
Properties
| Property | Value |
|---|---|
| applicant_name | ACTAVIS LABORATORIES FL INC AN INDIRECT WHOLLY OWNED SUB OF TEVA PHARMACEUTICALS USA INC |
| application_type | ANDA |
| approval_date | 2016-07-29 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 100MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 50MG BASE | TABLET, EXTENDED RELEASE;ORAL |
| DESVENLAFAXINE SUCCINATE | DESVENLAFAXINE SUCCINATE | EQ 25MG BASE | TABLET, EXTENDED RELEASE;ORAL |
3 products